# Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

Source: https://onco.cc/trials/nct06365788/  
OnCo record `nct06365788` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of abemaciclib and bicalutamide in triple-negative breast cancer, run by Universitaire Ziekenhuizen KU Leuven, now recruiting.

## Summary

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer is a phase 2, interventional study registered as NCT06365788 by Universitaire Ziekenhuizen KU Leuven, with a registry enrolment figure of 53 participants, started 2024-04-08 and due to reach its primary completion in 2027-12. Interventions recorded: Abemaciclib; Bicalutamide. Conditions listed: Triple Negative Breast Neoplasms. Triple-negative eligibility wording from the registry: "The patient has a biopsy-confirmed diagnosis of recurrent, unresectable, locally advanced, or metastatic AR+ TNBC". Sites: Belgium. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: ABBICAR
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT06365788
- Phase: 2
- Setting: A Multicenter Single Arm Phase II Study With Bicalutamide in Combination With Abemaciclib in 4 Cohorts of Locoregionally Advanced Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
- Sponsor: Universitaire Ziekenhuizen KU Leuven
- Enrolled: 53

## Sources

- ClinicalTrials.gov NCT06365788: https://clinicaltrials.gov/study/NCT06365788

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/), [Metastatic triple-negative breast cancer](https://onco.cc/cancers/tnbc-metastatic/)
- drugs: [Abemaciclib](https://onco.cc/drugs/abemaciclib/), [Bicalutamide](https://onco.cc/drugs/bicalutamide/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06365788.json